95 related articles for article (PubMed ID: 26878899)
1. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
Paricharak S; IJzerman AP; Bender A; Nigsch F
ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
[TBL] [Abstract][Full Text] [Related]
2. A High-Throughput HIV-1 Drug Screening Platform, Based on Lentiviral Vectors and Compatible with Biosafety Level-1.
Ellinger B; Pohlmann D; Woens J; Jäkel FM; Reinshagen J; Stocking C; Prassolov VS; Fehse B; Riecken K
Viruses; 2020 May; 12(5):. PubMed ID: 32466195
[TBL] [Abstract][Full Text] [Related]
3. AI is a viable alternative to high throughput screening: a 318-target study.
Atomwise AIMS Program
Sci Rep; 2024 Apr; 14(1):7526. PubMed ID: 38565852
[TBL] [Abstract][Full Text] [Related]
4. Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds.
Alves VM; Yasgar A; Wellnitz J; Rai G; Rath M; Braga RC; Capuzzi SJ; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
J Med Chem; 2023 Sep; 66(18):12828-12839. PubMed ID: 37677128
[TBL] [Abstract][Full Text] [Related]
5. High throughput screening for neurodegeneration and complex disease phenotypes.
Varma H; Lo DC; Stockwell BR
Comb Chem High Throughput Screen; 2008 Mar; 11(3):238-48. PubMed ID: 18336216
[TBL] [Abstract][Full Text] [Related]
6. Fused Tetrahydroquinolines Are Interfering with Your Assay.
Bashore FM; Annor-Gyamfi J; Du Y; Katis V; Nwogbo F; Flax RG; Frye SV; Pearce KH; Fu H; Willson TM; Drewry DH; Axtman AD
J Med Chem; 2023 Nov; 66(21):14434-14446. PubMed ID: 37874947
[TBL] [Abstract][Full Text] [Related]
7. Pooling in high-throughput drug screening.
Kainkaryam RM; Woolf PJ
Curr Opin Drug Discov Devel; 2009 May; 12(3):339-50. PubMed ID: 19396735
[TBL] [Abstract][Full Text] [Related]
8. Quantitative High-Throughput Screening Using a Coincidence Reporter Biocircuit.
Schuck BW; MacArthur R; Inglese J
Curr Protoc Neurosci; 2017 Apr; 79():5.32.1-5.32.27. PubMed ID: 28398644
[TBL] [Abstract][Full Text] [Related]
9. High-throughput nephelometry methodology for qualitative determination of aqueous solubility of chemical libraries.
Brea J; Varela MJ; Daudey GA; Loza MI
SLAS Discov; 2024 Apr; 29(3):100149. PubMed ID: 38492994
[TBL] [Abstract][Full Text] [Related]
10. The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.
Wagner BK; Schreiber SL
Cell Chem Biol; 2016 Jan; 23(1):3-9. PubMed ID: 26933731
[TBL] [Abstract][Full Text] [Related]
11. High Throughput, Label-free Screening Small Molecule Compound Libraries for Protein-Ligands using Combination of Small Molecule Microarrays and a Special Ellipsometry-based Optical Scanner.
Landry JP; Fei Y; Zhu XD
Int Drug Discov; 2011 Dec; ():8-13. PubMed ID: 22306883
[TBL] [Abstract][Full Text] [Related]
12. Maximizing gain in high-throughput screening using conformal prediction.
Svensson F; Afzal AM; Norinder U; Bender A
J Cheminform; 2018 Feb; 10(1):7. PubMed ID: 29468427
[TBL] [Abstract][Full Text] [Related]
13. Real-Time Biological Annotation of Synthetic Compounds.
Gerry CJ; Hua BK; Wawer MJ; Knowles JP; Nelson SD; Verho O; Dandapani S; Wagner BK; Clemons PA; Booker-Milburn KI; Boskovic ZV; Schreiber SL
J Am Chem Soc; 2016 Jul; 138(28):8920-7. PubMed ID: 27398798
[TBL] [Abstract][Full Text] [Related]
14. Automating the High-Throughput Screening of Protein-Based Optical Indicators and Actuators.
Lee J; Campillo B; Hamidian S; Liu Z; Shorey M; St-Pierre F
Biochemistry; 2023 Jan; 62(2):169-177. PubMed ID: 36315460
[TBL] [Abstract][Full Text] [Related]
15. Bioactivity profile of dissolved organic matter and its relation to molecular composition.
Catalá TS; Speidel LG; Wenzel-Storjohann A; Dittmar T; Tasdemir D
Nat Prod Bioprospect; 2023 Sep; 13(1):32. PubMed ID: 37721596
[TBL] [Abstract][Full Text] [Related]
16. QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping.
Škuta C; Cortés-Ciriano I; Dehaen W; Kříž P; van Westen GJP; Tetko IV; Bender A; Svozil D
J Cheminform; 2020 May; 12(1):39. PubMed ID: 33431038
[TBL] [Abstract][Full Text] [Related]
17. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
[TBL] [Abstract][Full Text] [Related]
18. Successive Statistical and Structure-Based Modeling to Identify Chemically Novel Kinase Inhibitors.
Burggraaff L; Lenselink EB; Jespers W; van Engelen J; Bongers BJ; González MG; Liu R; Hoos HH; van Vlijmen HWT; IJzerman AP; van Westen GJP
J Chem Inf Model; 2020 Sep; 60(9):4283-4295. PubMed ID: 32343143
[TBL] [Abstract][Full Text] [Related]
19. Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research.
David L; Arús-Pous J; Karlsson J; Engkvist O; Bjerrum EJ; Kogej T; Kriegl JM; Beck B; Chen H
Front Pharmacol; 2019; 10():1303. PubMed ID: 31749705
[TBL] [Abstract][Full Text] [Related]
20. Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability.
Laufkötter O; Sturm N; Bajorath J; Chen H; Engkvist O
J Cheminform; 2019 Aug; 11(1):54. PubMed ID: 31396716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
